Nextphase goes live with clinical trial based solution based on Microsoft.NET framework
"The Microsoft .NET framework provides the Nextphase ctSeries with greater reliability, scalability, and adaptability than traditional Internet technology standards such as J2EE, said Ed Risinger, COO of Nextphase. As a result, our clients can design and deploy clinical trials in a matter of days rather than months, which translates to faster time to market for new products. That's a critical factor in an industry where each day can represent up to $1 million in sales and earlier patient access to important new therapies."
Risinger also revealed the solution benefits from speed of deployment and is designed to incorporate virtually any new testing protocols into proprietary templates that are based on proven Microsoft development tools.
"We also offer our clients a significant cost advantage" Risinger adds, "since infrastructure-related deployment costs with .NET are effectively zero, outside of the cost for Microsoft Windows or another supported platform."